-
公开(公告)号:WO2016154580A1
公开(公告)日:2016-09-29
申请号:PCT/US2016/024308
申请日:2016-03-25
Applicant: AMGEN INC.
Inventor: CUI, Sheng , RANGANATHAN, Krishnakumar , CROCKETT, Richard , CHEN, Ying , SWIETLOW, Aleksander , CROSSLEY, Kevin , SHI, Yun , DECROOS, Karel , MONIOTTE, Etienne
CPC classification number: C07K1/026 , C07K1/18 , C07K5/081 , C07K5/1019 , C07K7/06
Abstract: The instant disclosure is directed to solution phase fragment coupling methods for preparing etelcalcetide and its pharmaceutically acceptable salts.
Abstract translation: 本公开涉及用于制备西替卡肽及其药学上可接受的盐的溶液相片段偶联方法。
-
公开(公告)号:EP3274360A1
公开(公告)日:2018-01-31
申请号:EP16720588.9
申请日:2016-03-25
Applicant: Amgen Inc.
Inventor: CUI, Sheng , RANGANATHAN, Krishnakumar , CROCKETT, Richard , CHEN, Ying , SWIETLOW, Aleksander , CROSSLEY, Kevin , SHI, Yun , DECROOS, Karel , MONIOTTE, Etienne
Abstract: The instant disclosure is directed to solution phase fragment coupling methods for preparing etelcalcetide and its pharmaceutically acceptable salts.
-
公开(公告)号:EP3274360B1
公开(公告)日:2020-05-06
申请号:EP16720588.9
申请日:2016-03-25
Applicant: Amgen Inc.
Inventor: CUI, Sheng , RANGANATHAN, Krishnakumar , CROCKETT, Richard , CHEN, Ying , SWIETLOW, Aleksander , CROSSLEY, Kevin , SHI, Yun , DECROOS, Karel , MONIOTTE, Etienne
-
-